DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF TIOTROPIUM AND FORMOTEROL?

被引:0
|
作者
Imran, M. [1 ]
Kotwani, A. [1 ]
Chhabra, S. [1 ]
Vijayan, V. [1 ]
机构
[1] VP Chest Inst, Delhi, India
关键词
D O I
10.1016/S1098-3015(10)73665-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A120 / A120
页数:1
相关论文
共 50 条
  • [31] High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
    Corradi, Massimo
    Spinola, Monica
    Petruzzelli, Stefano
    Kuna, Piotr
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (05) : 492 - 502
  • [32] Glycopyrrolate/Formoterol Fumarate Fixed-Dose Combination Delivered by Metered Dose Inhaler Improves Lung Function and Symptoms in Patients with COPD: Results from the PINNACLE-4 Study in Asia, Europe, and the USA
    Lipworth, B.
    Collier, D. J.
    Gon, Y.
    Zhong, N.
    Nishi, K.
    Chen, R.
    Arora, S.
    Maes, A.
    Siddiqui, S.
    Reisner, C.
    Martin, U. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Dose-Ranging Study of 2 Fixed-Dose Combinations of Twice-Daily Aclidinium Bromide Plus Formoterol in Patients With Moderate to Severe COPD
    Kerwin, Edward
    Lapidus, Robert
    Leselbaum, Anne
    Ortiz, Stephan
    Rowe, Paul
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [34] Formoterol treatment plus tiotropium results in greater improvements in lung function compared with tiotropium administered alone in patients with COPD
    Tashkin, D.
    Varghese, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S4 - S4
  • [35] ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Cazzola, M.
    Calzetta, L.
    Matera, M. G.
    DRUGS OF TODAY, 2015, 51 (02) : 97 - 105
  • [36] Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
    Lan, Ying
    Yang, Nan
    Wang, Yirong
    Yang, Yan
    Xu, Min
    He, Qin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2093 - 2103
  • [37] Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD
    Salvi, Sundeep
    Jain, Manish K.
    Krishnamurthy, Srikanth
    Balki, Akash
    Kodgule, Rahul
    Tandon, Monika
    Bhagat, Sagar
    Panchal, Sagar
    Khatri, Nishtha
    Wu, Wen
    Pendse, Amol
    Patil, Saiprasad
    Barkate, Hanmant
    LUNG INDIA, 2022, 39 (06) : 517 - 524
  • [38] Long-term Safety of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate in Patients With Stable Moderate to Severe COPD
    Make, Barry
    Donohue, James
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2014, 145 (03)
  • [39] Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients
    Busse, William W.
    Shah, Shailen R.
    Somerville, Laura
    Parasuraman, Bhash
    Martin, Paula
    Goldman, Mitchell
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) : 1407 - 1414
  • [40] Maintenance and reliever therapy with budesonide/formoterol versus fixed dose fluticasone/salmeterol in patients with COPD
    Muiser, S.
    Imkamp, K.
    Seigers, D.
    Halbersma, N.
    Vonk, J.
    Luijk, B.
    Braunstahl, G.
    Van den Berg, J. W.
    Kroesen, B.
    Kocks, J.
    Heijink, I
    Reddel, H.
    Kerstjens, H.
    Van den Berge, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60